M00001 |
952 | 93.2 |
4784 | 54.5 |
605 | 95.9 |
150 | 96.2 |
171 | 97.2 |
26 | 44.8 |
4665 | 55.9 |
119 | 27.5 |
Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate |
M00002 |
983 | 96.3 |
7668 | 87.4 |
611 | 96.8 |
151 | 96.8 |
171 | 97.2 |
50 | 86.2 |
7351 | 88.1 |
317 | 73.4 |
Glycolysis, core module involving three-carbon compounds |
M00003 |
922 | 90.3 |
5130 | 58.5 |
599 | 94.9 |
147 | 94.2 |
160 | 90.9 |
16 | 27.6 |
4961 | 59.5 |
169 | 39.1 |
Gluconeogenesis, oxaloacetate => fructose-6P |
M00004 |
908 | 88.9 |
4375 | 49.9 |
586 | 92.9 |
150 | 96.2 |
151 | 85.8 |
21 | 36.2 |
4375 | 52.4 |
0 | 0.0 |
Pentose phosphate pathway (Pentose phosphate cycle) |
M00005 |
1006 | 98.5 |
8504 | 96.9 |
627 | 99.4 |
155 | 99.4 |
169 | 96.0 |
55 | 94.8 |
8082 | 96.9 |
422 | 97.7 |
PRPP biosynthesis, ribose 5P => PRPP |
M00006 |
977 | 95.7 |
4957 | 56.5 |
613 | 97.1 |
152 | 97.4 |
169 | 96.0 |
43 | 74.1 |
4945 | 59.3 |
12 | 2.8 |
Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P |
M00007 |
939 | 92.0 |
6985 | 79.6 |
603 | 95.6 |
154 | 98.7 |
156 | 88.6 |
26 | 44.8 |
6940 | 83.2 |
45 | 10.4 |
Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P |
M00008 |
0 | 0.0 |
2282 | 26.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2282 | 27.4 |
0 | 0.0 |
Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate |
M00009 |
725 | 71.0 |
5692 | 64.9 |
496 | 78.6 |
80 | 51.3 |
145 | 82.4 |
4 | 6.9 |
5524 | 66.2 |
168 | 38.9 |
Citrate cycle (TCA cycle, Krebs cycle) |
M00010 |
951 | 93.1 |
7075 | 80.6 |
591 | 93.7 |
149 | 95.5 |
169 | 96.0 |
42 | 72.4 |
6823 | 81.8 |
252 | 58.3 |
Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate |
M00011 |
760 | 74.4 |
5970 | 68.0 |
526 | 83.4 |
84 | 53.8 |
145 | 82.4 |
5 | 8.6 |
5790 | 69.4 |
180 | 41.7 |
Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate |
M00012 |
316 | 31.0 |
3197 | 36.4 |
4 | 0.6 |
139 | 89.1 |
166 | 94.3 |
7 | 12.1 |
3140 | 37.6 |
57 | 13.2 |
Glyoxylate cycle |
M00013 |
215 | 21.1 |
0 | 0.0 |
130 | 20.6 |
1 | 0.6 |
84 | 47.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA |
M00014 |
536 | 52.5 |
0 | 0.0 |
536 | 84.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glucuronate pathway (uronate pathway) |
M00015 |
952 | 93.2 |
6585 | 75.1 |
615 | 97.5 |
153 | 98.1 |
164 | 93.2 |
20 | 34.5 |
6482 | 77.7 |
103 | 23.8 |
Proline biosynthesis, glutamate => proline |
M00016 |
0 | 0.0 |
4307 | 49.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4305 | 51.6 |
2 | 0.5 |
Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine |
M00017 |
119 | 11.7 |
2680 | 30.5 |
0 | 0.0 |
3 | 1.9 |
115 | 65.3 |
1 | 1.7 |
2680 | 32.1 |
0 | 0.0 |
Methionine biosynthesis, aspartate => homoserine => methionine |
M00018 |
308 | 30.2 |
6636 | 75.6 |
0 | 0.0 |
150 | 96.2 |
154 | 87.5 |
4 | 6.9 |
6377 | 76.4 |
259 | 60.0 |
Threonine biosynthesis, aspartate => homoserine => threonine |
M00019 |
313 | 30.7 |
6623 | 75.5 |
0 | 0.0 |
150 | 96.2 |
163 | 92.6 |
0 | 0.0 |
6339 | 76.0 |
284 | 65.7 |
Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine |
M00020 |
866 | 84.8 |
4658 | 53.1 |
580 | 91.9 |
153 | 98.1 |
124 | 70.5 |
9 | 15.5 |
4639 | 55.6 |
19 | 4.4 |
Serine biosynthesis, glycerate-3P => serine |
M00021 |
172 | 16.8 |
6099 | 69.5 |
0 | 0.0 |
156 | 100.0 |
1 | 0.6 |
15 | 25.9 |
5947 | 71.3 |
152 | 35.2 |
Cysteine biosynthesis, serine => cysteine |
M00022 |
318 | 31.1 |
4268 | 48.6 |
0 | 0.0 |
144 | 92.3 |
164 | 93.2 |
10 | 17.2 |
4258 | 51.0 |
10 | 2.3 |
Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate |
M00023 |
300 | 29.4 |
5540 | 63.1 |
0 | 0.0 |
146 | 93.6 |
154 | 87.5 |
0 | 0.0 |
5219 | 62.6 |
321 | 74.3 |
Tryptophan biosynthesis, chorismate => tryptophan |
M00024 |
114 | 11.2 |
1978 | 22.5 |
0 | 0.0 |
1 | 0.6 |
113 | 64.2 |
0 | 0.0 |
1978 | 23.7 |
0 | 0.0 |
Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine |
M00025 |
149 | 14.6 |
1392 | 15.9 |
0 | 0.0 |
0 | 0.0 |
149 | 84.7 |
0 | 0.0 |
1392 | 16.7 |
0 | 0.0 |
Tyrosine biosynthesis, chorismate => HPP => tyrosine |
M00026 |
286 | 28.0 |
4524 | 51.6 |
2 | 0.3 |
137 | 87.8 |
144 | 81.8 |
3 | 5.2 |
4450 | 53.3 |
74 | 17.1 |
Histidine biosynthesis, PRPP => histidine |
M00027 |
902 | 88.3 |
879 | 10.0 |
602 | 95.4 |
141 | 90.4 |
159 | 90.3 |
0 | 0.0 |
864 | 10.4 |
15 | 3.5 |
GABA (gamma-Aminobutyrate) shunt |
M00028 |
270 | 26.4 |
5687 | 64.8 |
0 | 0.0 |
153 | 98.1 |
114 | 64.8 |
3 | 5.2 |
5556 | 66.6 |
131 | 30.3 |
Ornithine biosynthesis, glutamate => ornithine |
M00029 |
365 | 35.7 |
0 | 0.0 |
360 | 57.1 |
0 | 0.0 |
0 | 0.0 |
5 | 8.6 |
0 | 0.0 |
0 | 0.0 |
Urea cycle |
M00030 |
143 | 14.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
143 | 81.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine |
M00031 |
0 | 0.0 |
155 | 1.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
55 | 0.7 |
100 | 23.1 |
Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine |
M00032 |
400 | 39.2 |
0 | 0.0 |
399 | 63.2 |
0 | 0.0 |
0 | 0.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
Lysine degradation, lysine => saccharopine => acetoacetyl-CoA |
M00033 |
0 | 0.0 |
990 | 11.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
975 | 11.7 |
15 | 3.5 |
Ectoine biosynthesis, aspartate => ectoine |
M00034 |
629 | 61.6 |
769 | 8.8 |
396 | 62.8 |
140 | 89.7 |
86 | 48.9 |
7 | 12.1 |
769 | 9.2 |
0 | 0.0 |
Methionine salvage pathway |
M00035 |
723 | 70.8 |
1064 | 12.1 |
613 | 97.1 |
2 | 1.3 |
99 | 56.2 |
9 | 15.5 |
1040 | 12.5 |
24 | 5.6 |
Methionine degradation |
M00036 |
743 | 72.8 |
988 | 11.3 |
502 | 79.6 |
138 | 88.5 |
95 | 54.0 |
8 | 13.8 |
988 | 11.8 |
0 | 0.0 |
Leucine degradation, leucine => acetoacetate + acetyl-CoA |
M00037 |
341 | 33.4 |
0 | 0.0 |
341 | 54.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Melatonin biosynthesis, animals, tryptophan => serotonin => melatonin |
M00038 |
406 | 39.8 |
58 | 0.7 |
403 | 63.9 |
0 | 0.0 |
3 | 1.7 |
0 | 0.0 |
58 | 0.7 |
0 | 0.0 |
Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate |
M00039 |
133 | 13.0 |
0 | 0.0 |
0 | 0.0 |
133 | 85.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Monolignol biosynthesis, phenylalanine/tyrosine => monolignol |
M00040 |
154 | 15.1 |
491 | 5.6 |
0 | 0.0 |
152 | 97.4 |
0 | 0.0 |
2 | 3.4 |
491 | 5.9 |
0 | 0.0 |
Tyrosine biosynthesis, chorismate => arogenate => tyrosine |
M00042 |
333 | 32.6 |
0 | 0.0 |
333 | 52.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline |
M00043 |
383 | 37.5 |
1 | 0.0 |
383 | 60.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine |
M00044 |
785 | 76.9 |
854 | 9.7 |
576 | 91.3 |
140 | 89.7 |
58 | 33.0 |
11 | 19.0 |
854 | 10.2 |
0 | 0.0 |
Tyrosine degradation, tyrosine => homogentisate |
M00045 |
441 | 43.2 |
3143 | 35.8 |
434 | 68.8 |
0 | 0.0 |
0 | 0.0 |
7 | 12.1 |
3088 | 37.0 |
55 | 12.7 |
Histidine degradation, histidine => N-formiminoglutamate => glutamate |
M00046 |
740 | 72.5 |
921 | 10.5 |
590 | 93.5 |
145 | 92.9 |
0 | 0.0 |
5 | 8.6 |
921 | 11.0 |
0 | 0.0 |
Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate |
M00047 |
375 | 36.7 |
0 | 0.0 |
372 | 59.0 |
0 | 0.0 |
0 | 0.0 |
3 | 5.2 |
0 | 0.0 |
0 | 0.0 |
Creatine pathway |
M00048 |
755 | 73.9 |
7082 | 80.7 |
495 | 78.4 |
134 | 85.9 |
125 | 71.0 |
1 | 1.7 |
6855 | 82.2 |
227 | 52.5 |
De novo purine biosynthesis, PRPP + glutamine => IMP |
M00049 |
960 | 94.0 |
7273 | 82.9 |
615 | 97.5 |
143 | 91.7 |
158 | 89.8 |
44 | 75.9 |
6875 | 82.4 |
398 | 92.1 |
Adenine ribonucleotide biosynthesis, IMP => ADP,ATP |
M00050 |
955 | 93.5 |
6865 | 78.2 |
606 | 96.0 |
150 | 96.2 |
155 | 88.1 |
44 | 75.9 |
6865 | 82.3 |
0 | 0.0 |
Guanine ribonucleotide biosynthesis, IMP => GDP,GTP |
M00051 |
694 | 68.0 |
1433 | 16.3 |
561 | 88.9 |
2 | 1.3 |
126 | 71.6 |
5 | 8.6 |
1137 | 13.6 |
296 | 68.5 |
De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP |
M00052 |
982 | 96.2 |
7399 | 84.3 |
619 | 98.1 |
155 | 99.4 |
160 | 90.9 |
48 | 82.8 |
6994 | 83.8 |
405 | 93.8 |
Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP |
M00053 |
985 | 96.5 |
6173 | 70.4 |
618 | 97.9 |
156 | 100.0 |
168 | 95.5 |
43 | 74.1 |
6060 | 72.6 |
113 | 26.2 |
Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP |
M00055 |
664 | 65.0 |
0 | 0.0 |
445 | 70.5 |
132 | 84.6 |
85 | 48.3 |
2 | 3.4 |
0 | 0.0 |
0 | 0.0 |
N-glycan precursor biosynthesis |
M00056 |
116 | 11.4 |
0 | 0.0 |
116 | 18.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
O-glycan biosynthesis, mucin type core |
M00057 |
519 | 50.8 |
0 | 0.0 |
518 | 82.1 |
0 | 0.0 |
0 | 0.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
Glycosaminoglycan biosynthesis, linkage tetrasaccharide |
M00058 |
520 | 50.9 |
0 | 0.0 |
520 | 82.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosaminoglycan biosynthesis, chondroitin sulfate backbone |
M00059 |
603 | 59.1 |
0 | 0.0 |
603 | 95.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosaminoglycan biosynthesis, heparan sulfate backbone |
M00060 |
0 | 0.0 |
802 | 9.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
802 | 9.6 |
0 | 0.0 |
KDO2-lipid A biosynthesis, Raetz pathway, LpxL-LpxM type |
M00061 |
0 | 0.0 |
1322 | 15.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1322 | 15.8 |
0 | 0.0 |
D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P |
M00063 |
0 | 0.0 |
3395 | 38.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3395 | 40.7 |
0 | 0.0 |
CMP-KDO biosynthesis |
M00064 |
0 | 0.0 |
1894 | 21.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1894 | 22.7 |
0 | 0.0 |
ADP-L-glycero-D-manno-heptose biosynthesis |
M00065 |
291 | 28.5 |
0 | 0.0 |
265 | 42.0 |
13 | 8.3 |
13 | 7.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
GPI-anchor biosynthesis, core oligosaccharide |
M00066 |
388 | 38.0 |
0 | 0.0 |
388 | 61.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lactosylceramide biosynthesis |
M00067 |
393 | 38.5 |
0 | 0.0 |
392 | 62.1 |
0 | 0.0 |
0 | 0.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid |
M00068 |
244 | 23.9 |
0 | 0.0 |
244 | 38.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer |
M00069 |
375 | 36.7 |
0 | 0.0 |
375 | 59.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 |
M00070 |
399 | 39.1 |
0 | 0.0 |
399 | 63.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer |
M00071 |
396 | 38.8 |
0 | 0.0 |
396 | 62.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer |
M00072 |
140 | 13.7 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
139 | 79.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
N-glycosylation by oligosaccharyltransferase |
M00073 |
816 | 79.9 |
0 | 0.0 |
536 | 84.9 |
143 | 91.7 |
134 | 76.1 |
3 | 5.2 |
0 | 0.0 |
0 | 0.0 |
N-glycan precursor trimming |
M00074 |
20 | 2.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
20 | 11.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
N-glycan biosynthesis, high-mannose type |
M00075 |
351 | 34.4 |
0 | 0.0 |
351 | 55.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
N-glycan biosynthesis, complex type |
M00076 |
413 | 40.5 |
0 | 0.0 |
413 | 65.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Dermatan sulfate degradation |
M00077 |
402 | 39.4 |
0 | 0.0 |
402 | 63.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Chondroitin sulfate degradation |
M00078 |
378 | 37.0 |
0 | 0.0 |
378 | 59.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Heparan sulfate degradation |
M00079 |
428 | 41.9 |
0 | 0.0 |
428 | 67.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Keratan sulfate degradation |
M00081 |
210 | 20.6 |
0 | 0.0 |
0 | 0.0 |
141 | 90.4 |
69 | 39.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pectin degradation |
M00082 |
916 | 89.7 |
5819 | 66.3 |
582 | 92.2 |
152 | 97.4 |
163 | 92.6 |
19 | 32.8 |
5819 | 69.8 |
0 | 0.0 |
Fatty acid biosynthesis, initiation |
M00083 |
945 | 92.6 |
6866 | 78.3 |
600 | 95.1 |
154 | 98.7 |
166 | 94.3 |
25 | 43.1 |
6866 | 82.3 |
0 | 0.0 |
Fatty acid biosynthesis, elongation |
M00085 |
630 | 61.7 |
0 | 0.0 |
617 | 97.8 |
0 | 0.0 |
5 | 2.8 |
8 | 13.8 |
0 | 0.0 |
0 | 0.0 |
Fatty acid elongation in mitochondria |
M00086 |
1020 | 99.9 |
6638 | 75.7 |
631 | 100.0 |
156 | 100.0 |
176 | 100.0 |
57 | 98.3 |
6409 | 76.8 |
229 | 53.0 |
beta-Oxidation, acyl-CoA synthesis |
M00087 |
842 | 82.5 |
2711 | 30.9 |
628 | 99.5 |
152 | 97.4 |
42 | 23.9 |
20 | 34.5 |
2711 | 32.5 |
0 | 0.0 |
beta-Oxidation |
M00088 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone |
M00089 |
884 | 86.6 |
0 | 0.0 |
618 | 97.9 |
155 | 99.4 |
89 | 50.6 |
22 | 37.9 |
0 | 0.0 |
0 | 0.0 |
Triacylglycerol biosynthesis |
M00090 |
576 | 56.4 |
0 | 0.0 |
552 | 87.5 |
0 | 0.0 |
24 | 13.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Phosphatidylcholine (PC) biosynthesis, choline => PC |
M00091 |
591 | 57.9 |
1201 | 13.7 |
406 | 64.3 |
3 | 1.9 |
165 | 93.8 |
17 | 29.3 |
1164 | 14.0 |
37 | 8.6 |
Phosphatidylcholine (PC) biosynthesis, PE => PC |
M00092 |
917 | 89.8 |
0 | 0.0 |
615 | 97.5 |
149 | 95.5 |
108 | 61.4 |
45 | 77.6 |
0 | 0.0 |
0 | 0.0 |
Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE |
M00093 |
159 | 15.6 |
5598 | 63.8 |
0 | 0.0 |
0 | 0.0 |
159 | 90.3 |
0 | 0.0 |
5598 | 67.1 |
0 | 0.0 |
Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE |
M00094 |
765 | 74.9 |
0 | 0.0 |
615 | 97.5 |
3 | 1.9 |
146 | 83.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
Ceramide biosynthesis |
M00095 |
789 | 77.3 |
103 | 1.2 |
526 | 83.4 |
137 | 87.8 |
118 | 67.0 |
8 | 13.8 |
60 | 0.7 |
43 | 10.0 |
C5 isoprenoid biosynthesis, mevalonate pathway |
M00096 |
149 | 14.6 |
2306 | 26.3 |
0 | 0.0 |
144 | 92.3 |
0 | 0.0 |
5 | 8.6 |
2306 | 27.6 |
0 | 0.0 |
C5 isoprenoid biosynthesis, non-mevalonate pathway |
M00097 |
137 | 13.4 |
36 | 0.4 |
0 | 0.0 |
137 | 87.8 |
0 | 0.0 |
0 | 0.0 |
36 | 0.4 |
0 | 0.0 |
beta-Carotene biosynthesis, GGAP => beta-carotene |
M00098 |
935 | 91.6 |
368 | 4.2 |
603 | 95.6 |
156 | 100.0 |
159 | 90.3 |
17 | 29.3 |
368 | 4.4 |
0 | 0.0 |
Acylglycerol degradation |
M00099 |
719 | 70.4 |
0 | 0.0 |
615 | 97.5 |
0 | 0.0 |
103 | 58.5 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
Sphingosine biosynthesis |
M00100 |
896 | 87.8 |
0 | 0.0 |
568 | 90.0 |
147 | 94.2 |
161 | 91.5 |
20 | 34.5 |
0 | 0.0 |
0 | 0.0 |
Sphingosine degradation |
M00101 |
286 | 28.0 |
0 | 0.0 |
286 | 45.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cholesterol biosynthesis, FPP => cholesterol |
M00102 |
119 | 11.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
119 | 67.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ergocalciferol biosynthesis, FPP => ergosterol/ergocalciferol |
M00103 |
328 | 32.1 |
0 | 0.0 |
328 | 52.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cholecalciferol biosynthesis |
M00104 |
31 | 3.0 |
0 | 0.0 |
31 | 4.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate |
M00106 |
146 | 14.3 |
0 | 0.0 |
146 | 23.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate |
M00107 |
361 | 35.4 |
0 | 0.0 |
361 | 57.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Steroid hormone biosynthesis, cholesterol => pregnenolone => progesterone |
M00108 |
28 | 2.7 |
0 | 0.0 |
28 | 4.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone |
M00109 |
274 | 26.8 |
0 | 0.0 |
274 | 43.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone |
M00110 |
373 | 36.5 |
0 | 0.0 |
373 | 59.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone |
M00112 |
155 | 15.2 |
72 | 0.8 |
0 | 0.0 |
151 | 96.8 |
0 | 0.0 |
4 | 6.9 |
72 | 0.9 |
0 | 0.0 |
Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol |
M00113 |
140 | 13.7 |
0 | 0.0 |
0 | 0.0 |
140 | 89.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Jasmonic acid biosynthesis |
M00114 |
144 | 14.1 |
0 | 0.0 |
0 | 0.0 |
144 | 92.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ascorbate biosynthesis, plants, fructose-6P => ascorbate |
M00115 |
141 | 13.8 |
4944 | 56.3 |
0 | 0.0 |
141 | 90.4 |
0 | 0.0 |
0 | 0.0 |
4944 | 59.3 |
0 | 0.0 |
NAD biosynthesis, aspartate => quinolinate => NAD |
M00116 |
0 | 0.0 |
1210 | 13.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1210 | 14.5 |
0 | 0.0 |
Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol |
M00117 |
0 | 0.0 |
1568 | 17.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1568 | 18.8 |
0 | 0.0 |
Ubiquinone biosynthesis, prokaryotes, chorismate (+ polyprenyl-PP) => ubiquinol |
M00118 |
846 | 82.9 |
3241 | 36.9 |
605 | 95.9 |
152 | 97.4 |
88 | 50.0 |
1 | 1.7 |
3240 | 38.8 |
1 | 0.2 |
Glutathione biosynthesis, glutamate => glutathione |
M00119 |
0 | 0.0 |
2838 | 32.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2838 | 34.0 |
0 | 0.0 |
Pantothenate biosynthesis, valine/L-aspartate => pantothenate |
M00120 |
696 | 68.2 |
7169 | 81.7 |
534 | 84.6 |
107 | 68.6 |
49 | 27.8 |
6 | 10.3 |
7169 | 85.9 |
0 | 0.0 |
Coenzyme A biosynthesis, pantothenate => CoA |
M00121 |
149 | 14.6 |
3173 | 36.2 |
0 | 0.0 |
145 | 92.9 |
0 | 0.0 |
4 | 6.9 |
3173 | 38.0 |
0 | 0.0 |
Heme biosynthesis, plants and bacteria, glutamate => heme |
M00122 |
0 | 0.0 |
2414 | 27.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2414 | 28.9 |
0 | 0.0 |
Cobalamin biosynthesis, cobyrinate a,c-diamide => cobalamin |
M00123 |
266 | 26.1 |
4555 | 51.9 |
0 | 0.0 |
152 | 97.4 |
109 | 61.9 |
5 | 8.6 |
4531 | 54.3 |
24 | 5.6 |
Biotin biosynthesis, pimeloyl-ACP/CoA => biotin |
M00124 |
0 | 0.0 |
1135 | 12.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1135 | 13.6 |
0 | 0.0 |
Pyridoxal-P biosynthesis, erythrose-4P => pyridoxal-P |
M00125 |
143 | 14.0 |
2424 | 27.6 |
0 | 0.0 |
143 | 91.7 |
0 | 0.0 |
0 | 0.0 |
2424 | 29.1 |
0 | 0.0 |
Riboflavin biosynthesis, plants and bacteria, GTP => riboflavin/FMN/FAD |
M00126 |
182 | 17.8 |
3426 | 39.0 |
0 | 0.0 |
122 | 78.2 |
60 | 34.1 |
0 | 0.0 |
3426 | 41.1 |
0 | 0.0 |
Tetrahydrofolate biosynthesis, GTP => THF |
M00127 |
0 | 0.0 |
654 | 7.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
649 | 7.8 |
5 | 1.2 |
Thiamine biosynthesis, prokaryotes, AIR (+ DXP/tyrosine) => TMP/TPP |
M00128 |
723 | 70.8 |
0 | 0.0 |
576 | 91.3 |
0 | 0.0 |
145 | 82.4 |
2 | 3.4 |
0 | 0.0 |
0 | 0.0 |
Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate + polyprenyl-PP => ubiquinol |
M00129 |
224 | 21.9 |
0 | 0.0 |
224 | 35.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ascorbate biosynthesis, animals, glucose-1P => ascorbate |
M00130 |
619 | 60.6 |
0 | 0.0 |
616 | 97.6 |
0 | 0.0 |
0 | 0.0 |
3 | 5.2 |
0 | 0.0 |
0 | 0.0 |
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 |
M00131 |
405 | 39.7 |
0 | 0.0 |
405 | 64.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol |
M00132 |
644 | 63.1 |
0 | 0.0 |
499 | 79.1 |
139 | 89.1 |
0 | 0.0 |
6 | 10.3 |
0 | 0.0 |
0 | 0.0 |
Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate |
M00133 |
0 | 0.0 |
1403 | 16.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1314 | 15.8 |
89 | 20.6 |
Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine |
M00134 |
890 | 87.2 |
669 | 7.6 |
592 | 93.8 |
111 | 71.2 |
165 | 93.8 |
22 | 37.9 |
668 | 8.0 |
1 | 0.2 |
Polyamine biosynthesis, arginine => ornithine => putrescine |
M00135 |
484 | 47.4 |
441 | 5.0 |
484 | 76.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
441 | 5.3 |
0 | 0.0 |
GABA biosynthesis, eukaryotes, putrescine => GABA |
M00136 |
0 | 0.0 |
198 | 2.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
198 | 2.4 |
0 | 0.0 |
GABA biosynthesis, prokaryotes, putrescine => GABA |
M00137 |
141 | 13.8 |
0 | 0.0 |
0 | 0.0 |
141 | 90.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Flavanone biosynthesis, phenylalanine => naringenin |
M00138 |
123 | 12.0 |
0 | 0.0 |
0 | 0.0 |
123 | 78.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Flavonoid biosynthesis, naringenin => pelargonidin |
M00140 |
0 | 0.0 |
2907 | 33.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2852 | 34.2 |
55 | 12.7 |
C1-unit interconversion, prokaryotes |
M00141 |
797 | 78.1 |
37 | 0.4 |
618 | 97.9 |
1 | 0.6 |
168 | 95.5 |
10 | 17.2 |
37 | 0.4 |
0 | 0.0 |
C1-unit interconversion, eukaryotes |
M00142 |
408 | 40.0 |
0 | 0.0 |
343 | 54.4 |
46 | 29.5 |
18 | 10.2 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
NADH:ubiquinone oxidoreductase, mitochondria |
M00143 |
653 | 64.0 |
0 | 0.0 |
480 | 76.1 |
64 | 41.0 |
107 | 60.8 |
2 | 3.4 |
0 | 0.0 |
0 | 0.0 |
NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria |
M00144 |
0 | 0.0 |
4058 | 46.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4058 | 48.6 |
0 | 0.0 |
NADH:quinone oxidoreductase, prokaryotes |
M00145 |
101 | 9.9 |
154 | 1.8 |
0 | 0.0 |
101 | 64.7 |
0 | 0.0 |
0 | 0.0 |
154 | 1.8 |
0 | 0.0 |
NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria |
M00146 |
238 | 23.3 |
0 | 0.0 |
238 | 37.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex |
M00147 |
198 | 19.4 |
0 | 0.0 |
198 | 31.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex |
M00148 |
795 | 77.9 |
0 | 0.0 |
548 | 86.8 |
85 | 54.5 |
157 | 89.2 |
5 | 8.6 |
0 | 0.0 |
0 | 0.0 |
Succinate dehydrogenase (ubiquinone) |
M00149 |
0 | 0.0 |
4196 | 47.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3975 | 47.7 |
221 | 51.2 |
Succinate dehydrogenase, prokaryotes |
M00150 |
0 | 0.0 |
918 | 10.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
918 | 11.0 |
0 | 0.0 |
Fumarate reductase, prokaryotes |
M00151 |
480 | 47.0 |
4192 | 47.8 |
367 | 58.2 |
77 | 49.4 |
27 | 15.3 |
9 | 15.5 |
4192 | 50.3 |
0 | 0.0 |
Cytochrome bc1 complex respiratory unit |
M00152 |
204 | 20.0 |
0 | 0.0 |
196 | 31.1 |
0 | 0.0 |
8 | 4.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cytochrome bc1 complex |
M00153 |
0 | 0.0 |
1540 | 17.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1540 | 18.5 |
0 | 0.0 |
Cytochrome bd ubiquinol oxidase |
M00154 |
199 | 19.5 |
0 | 0.0 |
199 | 31.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cytochrome c oxidase |
M00155 |
0 | 0.0 |
4643 | 52.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4528 | 54.3 |
115 | 26.6 |
Cytochrome c oxidase, prokaryotes |
M00156 |
0 | 0.0 |
2101 | 23.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2101 | 25.2 |
0 | 0.0 |
Cytochrome c oxidase, cbb3-type |
M00157 |
109 | 10.7 |
7335 | 83.6 |
0 | 0.0 |
109 | 69.9 |
0 | 0.0 |
0 | 0.0 |
7335 | 87.9 |
0 | 0.0 |
F-type ATPase, prokaryotes and chloroplasts |
M00158 |
183 | 17.9 |
0 | 0.0 |
165 | 26.1 |
0 | 0.0 |
18 | 10.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
F-type ATPase, eukaryotes |
M00159 |
0 | 0.0 |
583 | 6.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
273 | 3.3 |
310 | 71.8 |
V/A-type ATPase, prokaryotes |
M00160 |
495 | 48.5 |
0 | 0.0 |
495 | 78.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
V-type ATPase, eukaryotes |
M00161 |
114 | 11.2 |
147 | 1.7 |
0 | 0.0 |
113 | 72.4 |
0 | 0.0 |
1 | 1.7 |
147 | 1.8 |
0 | 0.0 |
Photosystem II |
M00162 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
Cytochrome b6f complex |
M00163 |
112 | 11.0 |
153 | 1.7 |
0 | 0.0 |
111 | 71.2 |
0 | 0.0 |
1 | 1.7 |
153 | 1.8 |
0 | 0.0 |
Photosystem I |
M00165 |
127 | 12.4 |
397 | 4.5 |
0 | 0.0 |
127 | 81.4 |
0 | 0.0 |
0 | 0.0 |
397 | 4.8 |
0 | 0.0 |
Reductive pentose phosphate cycle (Calvin cycle) |
M00168 |
164 | 16.1 |
3797 | 43.3 |
0 | 0.0 |
155 | 99.4 |
0 | 0.0 |
9 | 15.5 |
3575 | 42.9 |
222 | 51.4 |
CAM (Crassulacean acid metabolism), dark |
M00169 |
156 | 15.3 |
1232 | 14.0 |
0 | 0.0 |
151 | 96.8 |
0 | 0.0 |
5 | 8.6 |
1232 | 14.8 |
0 | 0.0 |
CAM (Crassulacean acid metabolism), light |
M00170 |
147 | 14.4 |
0 | 0.0 |
0 | 0.0 |
143 | 91.7 |
0 | 0.0 |
4 | 6.9 |
0 | 0.0 |
0 | 0.0 |
C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type |
M00171 |
142 | 13.9 |
0 | 0.0 |
0 | 0.0 |
142 | 91.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C4-dicarboxylic acid cycle, NAD - malic enzyme type |
M00172 |
120 | 11.8 |
0 | 0.0 |
0 | 0.0 |
120 | 76.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C4-dicarboxylic acid cycle, NADP - malic enzyme type |
M00173 |
0 | 0.0 |
30 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
30 | 0.4 |
0 | 0.0 |
Reductive citrate cycle (Arnon-Buchanan cycle) |
M00174 |
0 | 0.0 |
42 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
42 | 0.5 |
0 | 0.0 |
Methane oxidation, methanotroph, methane => formaldehyde |
M00175 |
0 | 0.0 |
791 | 9.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
721 | 8.6 |
70 | 16.2 |
Nitrogen fixation, nitrogen => ammonia |
M00176 |
299 | 29.3 |
2781 | 31.7 |
0 | 0.0 |
144 | 92.3 |
149 | 84.7 |
6 | 10.3 |
2760 | 33.1 |
21 | 4.9 |
Assimilatory sulfate reduction, sulfate => H2S |
M00307 |
952 | 93.2 |
8199 | 93.4 |
607 | 96.2 |
155 | 99.4 |
151 | 85.8 |
39 | 67.2 |
7808 | 93.6 |
391 | 90.5 |
Pyruvate oxidation, pyruvate => acetyl-CoA |
M00308 |
0 | 0.0 |
73 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
67 | 15.5 |
Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P |
M00309 |
0 | 0.0 |
52 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
52 | 12.0 |
Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate |
M00338 |
793 | 77.7 |
1242 | 14.2 |
622 | 98.6 |
2 | 1.3 |
157 | 89.2 |
12 | 20.7 |
1223 | 14.7 |
19 | 4.4 |
Cysteine biosynthesis, homocysteine + serine => cysteine |
M00344 |
68 | 6.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
68 | 38.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Formaldehyde assimilation, xylulose monophosphate pathway |
M00345 |
0 | 0.0 |
586 | 6.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
582 | 7.0 |
4 | 0.9 |
Formaldehyde assimilation, ribulose monophosphate pathway |
M00346 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
Formaldehyde assimilation, serine pathway |
M00356 |
0 | 0.0 |
53 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
53 | 12.3 |
Methanogenesis, methanol => methane |
M00357 |
0 | 0.0 |
81 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
81 | 18.8 |
Methanogenesis, acetate => methane |
M00358 |
0 | 0.0 |
55 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
54 | 12.5 |
Coenzyme M biosynthesis |
M00363 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
EHEC pathogenicity signature, Shiga toxin |
M00364 |
159 | 15.6 |
4032 | 46.0 |
0 | 0.0 |
153 | 98.1 |
0 | 0.0 |
6 | 10.3 |
3608 | 43.3 |
424 | 98.1 |
C10-C20 isoprenoid biosynthesis, bacteria |
M00365 |
0 | 0.0 |
1438 | 16.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1014 | 12.2 |
424 | 98.1 |
C10-C20 isoprenoid biosynthesis, archaea |
M00366 |
150 | 14.7 |
0 | 0.0 |
0 | 0.0 |
149 | 95.5 |
0 | 0.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
C10-C20 isoprenoid biosynthesis, plants |
M00367 |
749 | 73.4 |
0 | 0.0 |
576 | 91.3 |
0 | 0.0 |
158 | 89.8 |
15 | 25.9 |
0 | 0.0 |
0 | 0.0 |
C10-C20 isoprenoid biosynthesis, non-plant eukaryotes |
M00368 |
140 | 13.7 |
0 | 0.0 |
0 | 0.0 |
140 | 89.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ethylene biosynthesis, methionine => ethylene |
M00369 |
10 | 1.0 |
0 | 0.0 |
0 | 0.0 |
10 | 6.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cyanogenic glycoside biosynthesis, tyrosine => dhurrin |
M00370 |
9 | 0.9 |
0 | 0.0 |
0 | 0.0 |
9 | 5.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glucosinolate biosynthesis, tryptophan => glucobrassicin |
M00371 |
108 | 10.6 |
0 | 0.0 |
0 | 0.0 |
108 | 69.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Castasterone biosynthesis, campesterol => castasterone |
M00372 |
138 | 13.5 |
0 | 0.0 |
0 | 0.0 |
138 | 88.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Abscisic acid biosynthesis, beta-carotene => abscisic acid |
M00373 |
0 | 0.0 |
135 | 1.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
135 | 1.6 |
0 | 0.0 |
Ethylmalonyl pathway |
M00374 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
12 | 2.8 |
Dicarboxylate-hydroxybutyrate cycle |
M00375 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 10.0 |
Hydroxypropionate-hydroxybutylate cycle |
M00376 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
3-Hydroxypropionate bi-cycle |
M00377 |
0 | 0.0 |
53 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
53 | 0.6 |
0 | 0.0 |
Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) |
M00378 |
0 | 0.0 |
267 | 3.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
267 | 61.8 |
F420 biosynthesis, archaea |
M00415 |
912 | 89.3 |
0 | 0.0 |
612 | 97.0 |
144 | 92.3 |
127 | 72.2 |
29 | 50.0 |
0 | 0.0 |
0 | 0.0 |
Fatty acid elongation in endoplasmic reticulum |
M00416 |
0 | 0.0 |
487 | 5.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
487 | 5.8 |
0 | 0.0 |
Cytochrome aa3-600 menaquinol oxidase |
M00417 |
0 | 0.0 |
2081 | 23.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2081 | 24.9 |
0 | 0.0 |
Cytochrome o ubiquinol oxidase |
M00418 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Toluene degradation, anaerobic, toluene => benzoyl-CoA |
M00419 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
Cymene degradation, p-cymene => p-cumate |
M00422 |
0 | 0.0 |
99 | 1.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
98 | 22.7 |
Acetyl-CoA pathway, CO2 => acetyl-CoA |
M00432 |
312 | 30.6 |
6804 | 77.5 |
0 | 0.0 |
148 | 94.9 |
163 | 92.6 |
1 | 1.7 |
6513 | 78.1 |
291 | 67.4 |
Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate |
M00433 |
158 | 15.5 |
41 | 0.5 |
0 | 0.0 |
0 | 0.0 |
158 | 89.8 |
0 | 0.0 |
41 | 0.5 |
0 | 0.0 |
Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate |
M00525 |
0 | 0.0 |
475 | 5.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
475 | 5.7 |
0 | 0.0 |
Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine |
M00526 |
0 | 0.0 |
580 | 6.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
577 | 6.9 |
3 | 0.7 |
Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine |
M00527 |
149 | 14.6 |
1413 | 16.1 |
0 | 0.0 |
148 | 94.9 |
0 | 0.0 |
1 | 1.7 |
1312 | 15.7 |
101 | 23.4 |
Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine |
M00528 |
0 | 0.0 |
40 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
40 | 0.5 |
0 | 0.0 |
Nitrification, ammonia => nitrite |
M00529 |
0 | 0.0 |
297 | 3.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
297 | 3.6 |
0 | 0.0 |
Denitrification, nitrate => nitrogen |
M00530 |
0 | 0.0 |
1388 | 15.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1388 | 16.6 |
0 | 0.0 |
Dissimilatory nitrate reduction, nitrate => ammonia |
M00531 |
248 | 24.3 |
1533 | 17.5 |
0 | 0.0 |
152 | 97.4 |
91 | 51.7 |
5 | 8.6 |
1475 | 17.7 |
58 | 13.4 |
Assimilatory nitrate reduction, nitrate => ammonia |
M00532 |
120 | 11.8 |
0 | 0.0 |
0 | 0.0 |
120 | 76.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Photorespiration |
M00533 |
0 | 0.0 |
551 | 6.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
551 | 6.6 |
0 | 0.0 |
Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate |
M00534 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Naphthalene degradation, naphthalene => salicylate |
M00535 |
0 | 0.0 |
451 | 5.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
277 | 3.3 |
174 | 40.3 |
Isoleucine biosynthesis, pyruvate => 2-oxobutanoate |
M00537 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Xylene degradation, xylene => methylbenzoate |
M00538 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Toluene degradation, toluene => benzoate |
M00539 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate |
M00540 |
0 | 0.0 |
19 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
19 | 0.2 |
0 | 0.0 |
Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA |
M00541 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA |
M00542 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
EHEC/EPEC pathogenicity signature, T3SS and effectors |
M00543 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate |
M00544 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate |
M00545 |
0 | 0.0 |
361 | 4.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
361 | 4.3 |
0 | 0.0 |
Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA |
M00546 |
182 | 17.8 |
415 | 4.7 |
181 | 28.7 |
0 | 0.0 |
0 | 0.0 |
1 | 1.7 |
415 | 5.0 |
0 | 0.0 |
Purine degradation, xanthine => urea |
M00547 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol |
M00548 |
0 | 0.0 |
173 | 2.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
173 | 2.1 |
0 | 0.0 |
Benzene degradation, benzene => catechol |
M00549 |
995 | 97.5 |
4842 | 55.2 |
625 | 99.0 |
154 | 98.7 |
168 | 95.5 |
48 | 82.8 |
4828 | 57.9 |
14 | 3.2 |
Nucleotide sugar biosynthesis, glucose => UDP-glucose |
M00550 |
0 | 0.0 |
620 | 7.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
620 | 7.4 |
0 | 0.0 |
Ascorbate degradation, ascorbate => D-xylulose-5P |
M00551 |
0 | 0.0 |
586 | 6.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
586 | 7.0 |
0 | 0.0 |
Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol |
M00552 |
0 | 0.0 |
1039 | 11.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1039 | 12.5 |
0 | 0.0 |
D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P |
M00554 |
705 | 69.0 |
3142 | 35.8 |
555 | 88.0 |
2 | 1.3 |
148 | 84.1 |
0 | 0.0 |
3095 | 37.1 |
47 | 10.9 |
Nucleotide sugar biosynthesis, galactose => UDP-galactose |
M00555 |
612 | 59.9 |
2119 | 24.2 |
463 | 73.4 |
142 | 91.0 |
1 | 0.6 |
6 | 10.3 |
2119 | 25.4 |
0 | 0.0 |
Betaine biosynthesis, choline => betaine |
M00563 |
0 | 0.0 |
39 | 0.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
39 | 9.0 |
Methanogenesis, methylamine/dimethylamine/trimethylamine => methane |
M00564 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
Helicobacter pylori pathogenicity signature, cagA pathogenicity island |
M00565 |
0 | 0.0 |
592 | 6.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
592 | 7.1 |
0 | 0.0 |
Trehalose biosynthesis, D-glucose 1P => trehalose |
M00567 |
0 | 0.0 |
113 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
113 | 26.2 |
Methanogenesis, CO2 => methane |
M00568 |
0 | 0.0 |
708 | 8.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
708 | 8.5 |
0 | 0.0 |
Catechol ortho-cleavage, catechol => 3-oxoadipate |
M00569 |
0 | 0.0 |
275 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
275 | 3.3 |
0 | 0.0 |
Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA |
M00570 |
312 | 30.6 |
5974 | 68.1 |
0 | 0.0 |
150 | 96.2 |
162 | 92.0 |
0 | 0.0 |
5827 | 69.9 |
147 | 34.0 |
Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine |
M00572 |
0 | 0.0 |
1531 | 17.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1531 | 18.4 |
0 | 0.0 |
Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP |
M00573 |
0 | 0.0 |
63 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
63 | 0.8 |
0 | 0.0 |
Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin |
M00574 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
Pertussis pathogenicity signature, pertussis toxin |
M00575 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Pertussis pathogenicity signature, T1SS |
M00576 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
ETEC pathogenicity signature, heat-labile and heat-stable enterotoxins |
M00577 |
0 | 0.0 |
306 | 3.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
283 | 3.4 |
23 | 5.3 |
Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin |
M00579 |
0 | 0.0 |
5585 | 63.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5560 | 66.7 |
25 | 5.8 |
Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate |
M00580 |
0 | 0.0 |
693 | 7.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
425 | 5.1 |
268 | 62.0 |
Pentose phosphate pathway, archaea, fructose 6P => ribose 5P |
M00595 |
0 | 0.0 |
490 | 5.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
490 | 5.9 |
0 | 0.0 |
Thiosulfate oxidation by SOX complex, thiosulfate => sulfate |
M00596 |
0 | 0.0 |
136 | 1.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
131 | 1.6 |
5 | 1.2 |
Dissimilatory sulfate reduction, sulfate => H2S |
M00597 |
0 | 0.0 |
181 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
181 | 2.2 |
0 | 0.0 |
Anoxygenic photosystem II |
M00598 |
0 | 0.0 |
15 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
15 | 0.2 |
0 | 0.0 |
Anoxygenic photosystem I |
M00608 |
0 | 0.0 |
116 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
116 | 26.9 |
2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate |
M00609 |
0 | 0.0 |
276 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
276 | 3.3 |
0 | 0.0 |
Cysteine biosynthesis, methionine => cysteine |
M00611 |
115 | 11.3 |
150 | 1.7 |
0 | 0.0 |
115 | 73.7 |
0 | 0.0 |
0 | 0.0 |
150 | 1.8 |
0 | 0.0 |
Oxygenic photosynthesis in plants and cyanobacteria |
M00612 |
0 | 0.0 |
49 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
49 | 0.6 |
0 | 0.0 |
Anoxygenic photosynthesis in purple bacteria |
M00613 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Anoxygenic photosynthesis in green nonsulfur bacteria |
M00614 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Anoxygenic photosynthesis in green sulfur bacteria |
M00615 |
244 | 23.9 |
1508 | 17.2 |
0 | 0.0 |
152 | 97.4 |
87 | 49.4 |
5 | 8.6 |
1451 | 17.4 |
57 | 13.2 |
Nitrate assimilation |
M00616 |
1 | 0.1 |
1751 | 20.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
1751 | 21.0 |
0 | 0.0 |
Sulfate-sulfur assimilation |
M00617 |
0 | 0.0 |
124 | 1.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
124 | 28.7 |
Methanogen |
M00618 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
Acetogen |
M00620 |
0 | 0.0 |
67 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
67 | 15.5 |
Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate |
M00621 |
920 | 90.1 |
5973 | 68.1 |
586 | 92.9 |
153 | 98.1 |
156 | 88.6 |
25 | 43.1 |
5799 | 69.5 |
174 | 40.3 |
Glycine cleavage system |
M00622 |
0 | 0.0 |
192 | 2.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
192 | 2.3 |
0 | 0.0 |
Nicotinate degradation, nicotinate => fumarate |
M00623 |
0 | 0.0 |
63 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
63 | 0.8 |
0 | 0.0 |
Phthalate degradation, phthalate => protocatechuate |
M00624 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate |
M00625 |
0 | 0.0 |
22 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
22 | 0.3 |
0 | 0.0 |
Methicillin resistance |
M00627 |
0 | 0.0 |
1090 | 12.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1090 | 13.1 |
0 | 0.0 |
beta-Lactam resistance, Bla system |
M00630 |
49 | 4.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
49 | 27.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
D-Galacturonate degradation (fungi), D-galacturonate => glycerol |
M00631 |
0 | 0.0 |
940 | 10.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
940 | 11.3 |
0 | 0.0 |
D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P |
M00632 |
678 | 66.4 |
2783 | 31.7 |
539 | 85.4 |
1 | 0.6 |
138 | 78.4 |
0 | 0.0 |
2774 | 33.3 |
9 | 2.1 |
Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P |
M00633 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 10.0 |
Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P |
M00636 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
Phthalate degradation, phthalate => protocatechuate |
M00637 |
0 | 0.0 |
220 | 2.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
220 | 2.6 |
0 | 0.0 |
Anthranilate degradation, anthranilate => catechol |
M00638 |
0 | 0.0 |
62 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
62 | 0.7 |
0 | 0.0 |
Salicylate degradation, salicylate => gentisate |
M00639 |
0 | 0.0 |
122 | 1.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
122 | 1.5 |
0 | 0.0 |
Multidrug resistance, efflux pump MexCD-OprJ |
M00641 |
0 | 0.0 |
198 | 2.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
198 | 2.4 |
0 | 0.0 |
Multidrug resistance, efflux pump MexEF-OprN |
M00642 |
0 | 0.0 |
435 | 5.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
435 | 5.2 |
0 | 0.0 |
Multidrug resistance, efflux pump MexJK-OprM |
M00643 |
0 | 0.0 |
108 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
108 | 1.3 |
0 | 0.0 |
Multidrug resistance, efflux pump MexXY-OprM |
M00649 |
0 | 0.0 |
182 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
182 | 2.2 |
0 | 0.0 |
Multidrug resistance, efflux pump AdeABC |
M00651 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Vancomycin resistance, D-Ala-D-Lac type |
M00652 |
0 | 0.0 |
31 | 0.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
31 | 0.4 |
0 | 0.0 |
Vancomycin resistance, D-Ala-D-Ser type |
M00660 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
Xanthomonas spp. pathogenicity signature, T3SS and effectors |
M00661 |
7 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 4.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline |
M00664 |
0 | 0.0 |
93 | 1.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
93 | 1.1 |
0 | 0.0 |
Nodulation |
M00672 |
6 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 3.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin |
M00673 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C |
M00674 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate |
M00675 |
0 | 0.0 |
17 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
17 | 0.2 |
0 | 0.0 |
Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate |
M00696 |
0 | 0.0 |
252 | 2.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
252 | 3.0 |
0 | 0.0 |
Multidrug resistance, efflux pump AcrEF-TolC |
M00697 |
0 | 0.0 |
83 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
83 | 1.0 |
0 | 0.0 |
Multidrug resistance, efflux pump MdtEF-TolC |
M00698 |
0 | 0.0 |
298 | 3.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
298 | 3.6 |
0 | 0.0 |
Multidrug resistance, efflux pump BpeEF-OprC |
M00700 |
0 | 0.0 |
239 | 2.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
239 | 2.9 |
0 | 0.0 |
Multidrug resistance, efflux pump AbcA |
M00702 |
0 | 0.0 |
108 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
108 | 1.3 |
0 | 0.0 |
Multidrug resistance, efflux pump NorB |
M00704 |
0 | 0.0 |
68 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
68 | 0.8 |
0 | 0.0 |
Tetracycline resistance, efflux pump Tet38 |
M00705 |
0 | 0.0 |
205 | 2.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
205 | 2.5 |
0 | 0.0 |
Multidrug resistance, efflux pump MepA |
M00714 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
Multidrug resistance, efflux pump QacA |
M00718 |
0 | 0.0 |
29 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
29 | 0.3 |
0 | 0.0 |
Multidrug resistance, efflux pump MexAB-OprM |
M00725 |
0 | 0.0 |
93 | 1.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
93 | 1.1 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, dltABCD operon |
M00726 |
0 | 0.0 |
102 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
102 | 1.2 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, lysyl-phosphatidylglycerol (L-PG) synthase MprF |
M00730 |
0 | 0.0 |
77 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
77 | 0.9 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, VraFG transporter |
M00736 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A |
M00740 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
14 | 3.2 |
Methylaspartate cycle |
M00741 |
440 | 43.1 |
1360 | 15.5 |
426 | 67.5 |
3 | 1.9 |
0 | 0.0 |
11 | 19.0 |
1218 | 14.6 |
142 | 32.9 |
Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA |
M00744 |
0 | 0.0 |
55 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
55 | 0.7 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, protease PgtE |
M00745 |
0 | 0.0 |
213 | 2.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
213 | 2.6 |
0 | 0.0 |
Imipenem resistance, repression of porin OprD |
M00746 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
Multidrug resistance, repression of porin OmpF |
M00761 |
0 | 0.0 |
578 | 6.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
578 | 6.9 |
0 | 0.0 |
Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N |
M00763 |
0 | 0.0 |
165 | 1.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
165 | 38.2 |
Ornithine biosynthesis, mediated by LysW, glutamate => ornithine |
M00769 |
0 | 0.0 |
20 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
20 | 0.2 |
0 | 0.0 |
Multidrug resistance, efflux pump MexPQ-OpmE |
M00773 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin |
M00774 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B |
M00775 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin |
M00776 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin |
M00777 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b |
M00778 |
0 | 0.0 |
121 | 1.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
121 | 1.5 |
0 | 0.0 |
Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide |
M00779 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin |
M00780 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline |
M00781 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone |
M00782 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin |
M00783 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C |
M00784 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A |
M00785 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cycloserine biosynthesis, arginine/serine => cycloserine |
M00786 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A |
M00787 |
0 | 0.0 |
62 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
62 | 0.7 |
0 | 0.0 |
Bacilysin biosynthesis, prephenate => bacilysin |
M00788 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Terpentecin biosynthesis, GGAP => terpentecin |
M00789 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Rebeccamycin biosynthesis, tryptophan => rebeccamycin |
M00790 |
0 | 0.0 |
48 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
48 | 0.6 |
0 | 0.0 |
Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin |
M00793 |
0 | 0.0 |
5163 | 58.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4975 | 59.6 |
188 | 43.5 |
dTDP-L-rhamnose biosynthesis |
M00794 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
dTDP-6-deoxy-D-allose biosynthesis |
M00795 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
dTDP-beta-L-noviose biosynthesis |
M00796 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
dTDP-D-mycaminose biosynthesis |
M00797 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
dTDP-D-desosamine biosynthesis |
M00798 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
dTDP-L-mycarose biosynthesis |
M00799 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
dTDP-L-oleandrose biosynthesis |
M00800 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
dTDP-L-megosamine biosynthesis |
M00801 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
dTDP-L-olivose biosynthesis |
M00802 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
dTDP-D-forosamine biosynthesis |
M00803 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
dTDP-D-angolosamine biosynthesis |
M00804 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Complete nitrification, comammox, ammonia => nitrite => nitrate |
M00805 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Staurosporine biosynthesis, tryptophan => staurosporine |
M00808 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
Violacein biosynthesis, tryptophan => violacein |
M00810 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde |
M00811 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde |
M00814 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose |
M00815 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A |
M00819 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone |
M00823 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Chlortetracycline biosynthesis, pretetramide => chlortetracycline |
M00824 |
0 | 0.0 |
40 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
40 | 0.5 |
0 | 0.0 |
9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core |
M00825 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core |
M00826 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA |
M00827 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP |
M00828 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP |
M00829 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA |
M00830 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA |
M00831 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA |
M00832 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP |
M00833 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Calicheamicin biosynthesis, calicheamicinone => calicheamicin |
M00834 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP |
M00835 |
0 | 0.0 |
23 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
23 | 0.3 |
0 | 0.0 |
Pyocyanine biosynthesis, chorismate => pyocyanine |
M00836 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
45 | 10.4 |
Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 |
M00837 |
0 | 0.0 |
17 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
17 | 0.2 |
0 | 0.0 |
Prodigiosin biosynthesis, L-proline => prodigiosin |
M00838 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin |
M00840 |
0 | 0.0 |
82 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
82 | 1.0 |
0 | 0.0 |
Tetrahydrofolate biosynthesis, mediated by ribA and trpF, GTP => THF |
M00841 |
15 | 1.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
15 | 25.9 |
0 | 0.0 |
0 | 0.0 |
Tetrahydrofolate biosynthesis, mediated by PTPS, GTP => THF |
M00842 |
586 | 57.4 |
0 | 0.0 |
582 | 92.2 |
0 | 0.0 |
0 | 0.0 |
4 | 6.9 |
0 | 0.0 |
0 | 0.0 |
Tetrahydrobiopterin biosynthesis, GTP => BH4 |
M00843 |
0 | 0.0 |
18 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
18 | 0.2 |
0 | 0.0 |
L-threo-Tetrahydrobiopterin biosynthesis, GTP => L-threo-BH4 |
M00844 |
715 | 70.0 |
6524 | 74.4 |
397 | 62.9 |
153 | 98.1 |
159 | 90.3 |
6 | 10.3 |
6165 | 73.9 |
359 | 83.1 |
Arginine biosynthesis, ornithine => arginine |
M00845 |
0 | 0.0 |
134 | 1.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
134 | 1.6 |
0 | 0.0 |
Arginine biosynthesis, glutamate => acetylcitrulline => arginine |
M00846 |
0 | 0.0 |
2537 | 28.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2535 | 30.4 |
2 | 0.5 |
Siroheme biosynthesis, glutamyl-tRNA => siroheme |
M00847 |
0 | 0.0 |
273 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
161 | 1.9 |
112 | 25.9 |
Heme biosynthesis, archaea, siroheme => heme |
M00848 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Aurachin biosynthesis, anthranilate => aurachin A |
M00849 |
0 | 0.0 |
355 | 4.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
355 | 82.2 |
C5 isoprenoid biosynthesis, mevalonate pathway, archaea |
M00850 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Vibrio cholerae pathogenicity signature, cholera toxins |
M00851 |
0 | 0.0 |
136 | 1.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
136 | 1.6 |
0 | 0.0 |
Carbapenem resistance |
M00852 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Vibrio cholerae pathogenicity signature, toxin coregulated pilus |
M00853 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
ETEC pathogenicity signature, colonization factors |
M00854 |
803 | 78.6 |
3729 | 42.5 |
504 | 79.9 |
153 | 98.1 |
144 | 81.8 |
2 | 3.4 |
3712 | 44.5 |
17 | 3.9 |
Glycogen biosynthesis, glucose-1P => glycogen/starch |
M00855 |
778 | 76.2 |
1371 | 15.6 |
613 | 97.1 |
0 | 0.0 |
153 | 86.9 |
12 | 20.7 |
1370 | 16.4 |
1 | 0.2 |
Glycogen degradation, glycogen => glucose-6P |
M00856 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Salmonella enterica pathogenicity signature, typhoid toxin |
M00857 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Salmonella enterica pathogenicity signature, Vi antigen |
M00859 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
Bacillus anthracis pathogenicity signature, anthrax toxin |
M00860 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Bacillus anthracis pathogenicity signature, polyglutamic acid capsule biosynthesis |
M00861 |
582 | 57.0 |
0 | 0.0 |
579 | 91.8 |
0 | 0.0 |
0 | 0.0 |
3 | 5.2 |
0 | 0.0 |
0 | 0.0 |
beta-Oxidation, peroxisome, VLCFA |
M00862 |
247 | 24.2 |
0 | 0.0 |
247 | 39.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA |
M00866 |
0 | 0.0 |
68 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
68 | 0.8 |
0 | 0.0 |
KDO2-lipid A biosynthesis, Raetz pathway, non-LpxL-LpxM type |
M00867 |
0 | 0.0 |
59 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
59 | 0.7 |
0 | 0.0 |
KDO2-lipid A modification pathway |
M00868 |
598 | 58.6 |
13 | 0.1 |
463 | 73.4 |
0 | 0.0 |
135 | 76.7 |
0 | 0.0 |
13 | 0.2 |
0 | 0.0 |
Heme biosynthesis, animals and fungi, glycine => heme |
M00872 |
320 | 31.3 |
0 | 0.0 |
319 | 50.6 |
0 | 0.0 |
0 | 0.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
O-glycan biosynthesis, mannose type (core M3) |
M00873 |
228 | 22.3 |
0 | 0.0 |
228 | 36.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fatty acid biosynthesis in mitochondria, animals |
M00874 |
37 | 3.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
37 | 21.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fatty acid biosynthesis in mitochondria, fungi |
M00875 |
0 | 0.0 |
74 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
74 | 0.9 |
0 | 0.0 |
Staphyloferrin B biosynthesis, L-serine => staphyloferrin B |
M00876 |
0 | 0.0 |
109 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
109 | 1.3 |
0 | 0.0 |
Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A |
M00877 |
0 | 0.0 |
71 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
71 | 0.9 |
0 | 0.0 |
Kanosamine biosynthesis, glucose 6-phosphate => kanosamine |
M00878 |
0 | 0.0 |
188 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
188 | 2.3 |
0 | 0.0 |
Phenylacetate degradation, phenylaxetate => acetyl-CoA/succinyl-CoA |
M00879 |
0 | 0.0 |
901 | 10.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
901 | 10.8 |
0 | 0.0 |
Arginine succinyltransferase pathway, arginine => glutamate |
M00880 |
684 | 67.0 |
4178 | 47.6 |
534 | 84.6 |
136 | 87.2 |
14 | 8.0 |
0 | 0.0 |
3819 | 45.8 |
359 | 83.1 |
Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor |
M00881 |
165 | 16.2 |
5716 | 65.1 |
0 | 0.0 |
149 | 95.5 |
0 | 0.0 |
16 | 27.6 |
5705 | 68.4 |
11 | 2.5 |
Lipoic acid biosynthesis, plants and bacteria, octanoyl-ACP => dihydrolipoyl-E2/H |
M00882 |
835 | 81.8 |
0 | 0.0 |
527 | 83.5 |
148 | 94.9 |
158 | 89.8 |
2 | 3.4 |
0 | 0.0 |
0 | 0.0 |
Lipoic acid biosynthesis, eukaryotes, octanoyl-ACP => dihydrolipoyl-H |
M00883 |
507 | 49.7 |
485 | 5.5 |
507 | 80.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
485 | 5.8 |
0 | 0.0 |
Lipoic acid biosynthesis, animals and bacteria, octanoyl-ACP => dihydrolipoyl-H => dihydrolipoyl-E2 |
M00884 |
40 | 3.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
40 | 22.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lipoic acid biosynthesis, octanoyl-CoA => dihydrolipoyl-E2 |
M00889 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Puromycin biosynthesis, ATP => puromycin |
M00890 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Roseoflavin biosynthesis, FMN => roseoflavin |
M00891 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ditryptophenaline biosynthesis, tryptophan + phenylalanine => ditryptophenaline |
M00892 |
933 | 91.4 |
0 | 0.0 |
612 | 97.0 |
146 | 93.6 |
160 | 90.9 |
15 | 25.9 |
0 | 0.0 |
0 | 0.0 |
UDP-N-acetyl-D-glucosamine biosynthesis, eukaryotes, glucose => UDP-GlcNAc |
M00893 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lovastatin biosynthesis, malonyl-CoA => lovastatin acid |
M00894 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cannabidiol biosynthesis, malonyl-CoA => cannabidiol/dronabinol |
M00895 |
0 | 0.0 |
80 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
80 | 1.0 |
0 | 0.0 |
Thiamine biosynthesis, prokaryotes, AIR (+ DXP/glycine) => TMP/TPP |
M00896 |
0 | 0.0 |
349 | 4.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
60 | 0.7 |
289 | 66.9 |
Thiamine biosynthesis, archaea, AIR (+ NAD+) => TMP/TPP |
M00897 |
119 | 11.7 |
0 | 0.0 |
0 | 0.0 |
119 | 76.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Thiamine biosynthesis, plants, AIR (+ NAD+) => TMP/thiamine/TPP |
M00898 |
82 | 8.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
82 | 46.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Thiamine biosynthesis, pyridoxal-5P => TMP/thiamine/TPP |
M00899 |
145 | 14.2 |
2840 | 32.4 |
0 | 0.0 |
144 | 92.3 |
0 | 0.0 |
1 | 1.7 |
2688 | 32.2 |
152 | 35.2 |
Thiamine salvage pathway, HMP/HET => TMP |
M00900 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Crocin biosynthesis, crocetin => crocin |
M00901 |
3 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline |
M00902 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin |
M00903 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fosfomycin biosynthesis, phosphoenolpyruvate => fosfomycin |
M00904 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Dapdiamides biosynthesis, L-2,3-diaminopropanoate => dapdiamide A/B/C |
M00905 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Grixazone biosynthesis, aspartate 4-semialdehyde => grixazone B |
M00906 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Ethynylserine biosynthesis, lysine => ethynylserine |
M00909 |
0 | 0.0 |
5414 | 61.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5414 | 64.9 |
0 | 0.0 |
UDP-N-acetyl-D-glucosamine biosynthesis, prokaryotes, glucose => UDP-GlcNAc |
M00910 |
152 | 14.9 |
0 | 0.0 |
0 | 0.0 |
151 | 96.8 |
0 | 0.0 |
1 | 1.7 |
0 | 0.0 |
0 | 0.0 |
Phenylalanine biosynthesis, chorismate => arogenate => phenylalanine |
M00911 |
37 | 3.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
37 | 21.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Riboflavin biosynthesis, fungi, GTP => riboflavin/FMN/FAD |
M00912 |
375 | 36.7 |
67 | 0.8 |
311 | 49.3 |
0 | 0.0 |
63 | 35.8 |
1 | 1.7 |
67 | 0.8 |
0 | 0.0 |
NAD biosynthesis, tryptophan => quinolinate => NAD |
M00913 |
46 | 4.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
46 | 26.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pantothenate biosynthesis, 2-oxoisovalerate/spermine => pantothenate |
M00914 |
0 | 0.0 |
152 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
152 | 35.2 |
Coenzyme A biosynthesis, archaea, 2-oxoisovalerate => 4-phosphopantoate => CoA |
M00915 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Caffeine degradation, caffeine => xanthine |
M00916 |
363 | 35.6 |
2754 | 31.4 |
32 | 5.1 |
153 | 98.1 |
153 | 86.9 |
25 | 43.1 |
2377 | 28.5 |
377 | 87.3 |
Pyridoxal-P biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P |
M00917 |
136 | 13.3 |
0 | 0.0 |
0 | 0.0 |
136 | 87.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Phytosterol biosynthesis, squalene 2,3-epoxide => campesterol/sitosterol |
M00918 |
0 | 0.0 |
194 | 2.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
194 | 2.3 |
0 | 0.0 |
Aerobactin biosynthesis, lysine => aerobactin |
M00919 |
0 | 0.0 |
320 | 3.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
320 | 3.8 |
0 | 0.0 |
Ectoine degradation, ectoine => aspartate |
M00921 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Cyclooctatin biosynthesis, dimethylallyl-PP + isopentenyl-PP => cyclooctatin |
M00922 |
0 | 0.0 |
89 | 1.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
89 | 1.1 |
0 | 0.0 |
CMP-Neu5Ac biosynthesis |
M00923 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
UDP-L-FucNAm biosynthesis |
M00924 |
0 | 0.0 |
658 | 7.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
604 | 7.2 |
54 | 12.5 |
Cobalamin biosynthesis, anaerobic, uroporphyrinogen III => sirohydrochlorin => cobyrinate a,c-diamide |
M00925 |
0 | 0.0 |
271 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
271 | 3.2 |
0 | 0.0 |
Cobalamin biosynthesis, aerobic, uroporphyrinogen III => precorrin 2 => cobyrinate a,c-diamide |
M00926 |
0 | 0.0 |
1460 | 16.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1460 | 17.5 |
0 | 0.0 |
Heme biosynthesis, bacteria, glutamyl-tRNA => coproporphyrin III => heme |
M00927 |
135 | 13.2 |
0 | 0.0 |
0 | 0.0 |
135 | 86.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Gibberellin A12 biosynthesis, GAPP => GA12 |
M00928 |
141 | 13.8 |
0 | 0.0 |
0 | 0.0 |
141 | 90.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Gibberellin A4/A1 biosynthesis, GA12/GA53 => GA4/GA1 |
M00929 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Gibberellin A1 biosynthesis, GGPP => GA1 |
M00930 |
0 | 0.0 |
448 | 5.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
448 | 5.4 |
0 | 0.0 |
Menaquinone biosynthesis, futalosine pathway |
M00931 |
0 | 0.0 |
224 | 2.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
224 | 2.7 |
0 | 0.0 |
Menaquinone biosynthesis, modified futalosine pathway |
M00932 |
133 | 13.0 |
59 | 0.7 |
0 | 0.0 |
133 | 85.3 |
0 | 0.0 |
0 | 0.0 |
59 | 0.7 |
0 | 0.0 |
Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol |
M00933 |
148 | 14.5 |
0 | 0.0 |
0 | 0.0 |
146 | 93.6 |
0 | 0.0 |
2 | 3.4 |
0 | 0.0 |
0 | 0.0 |
Plastoquinone biosynthesis, homogentisate + solanesyl-PP => plastoquinol |
M00934 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Mycinamicin biosynthesis, malonyl-CoA + methylmalonyl-CoA => protomycinolide IV => mycinamicin II |
M00935 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 10.0 |
Methanofuran biosynthesis |
M00936 |
66 | 6.5 |
0 | 0.0 |
0 | 0.0 |
66 | 42.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Melatonin biosynthesis, plants, tryptophan => serotonin => melatonin |
M00937 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1 |
M00938 |
867 | 84.9 |
4516 | 51.5 |
539 | 85.4 |
154 | 98.7 |
134 | 76.1 |
40 | 69.0 |
4444 | 53.3 |
72 | 16.7 |
Pyrimidine deoxyribonucleotide biosynthesis, UDP => dTTP |
M00939 |
0 | 0.0 |
315 | 3.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
315 | 3.8 |
0 | 0.0 |
Pyrimidine degradation, uracil => 3-hydroxypropanoate |
M00940 |
44 | 4.3 |
0 | 0.0 |
0 | 0.0 |
44 | 28.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Flavanone biosynthesis, p-coumaroyl-CoA => liquiritigenin |
M00941 |
19 | 1.9 |
0 | 0.0 |
0 | 0.0 |
19 | 12.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Isoflavone biosynthesis, liquiritigenin/naringenin => daidzein/genistein |
M00942 |
17 | 1.7 |
0 | 0.0 |
0 | 0.0 |
17 | 10.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pterocarpan biosynthesis, daidzein => medicarpin |
M00943 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Reticuline biosynthesis, dopamine + 4HPAA => (S)-reticuline |
M00944 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Morphine biosynthesis, (S)-reticuline => morphine |
M00945 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Sanguinarine biosynthesis, (S)-reticuline => sanguinarine |
M00946 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Noscapine biosynthesis, (S)-reticuline => noscapine |
M00947 |
0 | 0.0 |
115 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
115 | 1.4 |
0 | 0.0 |
D-Arginine racemization, D-arginine => L-arginine |
M00948 |
0 | 0.0 |
514 | 5.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
514 | 6.2 |
0 | 0.0 |
Hydroxyproline degradation, trans-4-hydroxy-L-proline => 2-oxoglutarate |
M00949 |
0 | 0.0 |
119 | 1.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
119 | 1.4 |
0 | 0.0 |
Staphylopine biosynthesis, L-histidine => staphylopine |
M00950 |
0 | 0.0 |
139 | 1.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
100 | 1.2 |
39 | 9.0 |
Biotin biosynthesis, BioU pathway, pimeloyl-ACP/CoA => biotin |
M00951 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cremeomycin biosynthesis, aspartate/3,4-AHBA => cremeomycin |
M00952 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Benzoxazinoid biosynthesis, indoleglycerol phosphate => DIMBOA-glucoside |
M00953 |
17 | 1.7 |
0 | 0.0 |
0 | 0.0 |
17 | 10.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Mugineic acid biosynthesis, methionine => 3-epihydroxymugineic acid |
M00956 |
0 | 0.0 |
183 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
183 | 2.2 |
0 | 0.0 |
Lysine degradation, bacteria, L-lysine => succinate |
M00957 |
0 | 0.0 |
162 | 1.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
162 | 1.9 |
0 | 0.0 |
Lysine degradation, bacteria, L-lysine => glutarate => succinate/acetyl-CoA |
M00958 |
633 | 62.0 |
2229 | 25.4 |
586 | 92.9 |
0 | 0.0 |
38 | 21.6 |
9 | 15.5 |
2229 | 26.7 |
0 | 0.0 |
Adenine ribonucleotide degradation, AMP => Urate |
M00959 |
583 | 57.1 |
1779 | 20.3 |
563 | 89.2 |
0 | 0.0 |
16 | 9.1 |
4 | 6.9 |
1779 | 21.3 |
0 | 0.0 |
Guanine ribonucleotide degradation, GMP => Urate |
M00960 |
0 | 0.0 |
25 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
25 | 0.3 |
0 | 0.0 |
Lysine degradation, bacteria, L-lysine => D-lysine => succinate |
M00961 |
4 | 0.4 |
0 | 0.0 |
0 | 0.0 |
4 | 2.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Betacyanin biosynthesis, L-tyrosine => amaranthin |
M00962 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Psilocybin biosynthesis, tryptophan => psilocybin |
M00963 |
6 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 3.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Chanoclavine aldehyde biosynthesis, tryptophan => chanoclavine-I aldehyde |
M00964 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumigaclavine biosynthesis, chanoclavine-I aldehyde => fumigaclavine C |
M00965 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Vindoline biosynthesis, tabersonine => vindoline |
M00966 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Equol biosynthesis, daidzein => equol |
M00967 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Flavone degradation, luteolin/apigenin => DHCA/phloretate |
M00968 |
0 | 0.0 |
221 | 2.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
220 | 50.9 |
Pentose bisphosphate pathway (nucleoside degradation), archaea, nucleoside/NMP => 3-PGA/glycerone phosphate |
M00969 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumagillin biosynthesis, farnesyl-PP => fumagillin |
M00970 |
877 | 85.9 |
5561 | 63.4 |
592 | 93.8 |
151 | 96.8 |
106 | 60.2 |
28 | 48.3 |
5539 | 66.4 |
22 | 5.1 |
Proline degradation, proline => glutamate |
M00971 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
QS-7 biosynthesis, 2,3-epoxysqualene => QS-7 |
M00972 |
876 | 85.8 |
1432 | 16.3 |
609 | 96.5 |
147 | 94.2 |
103 | 58.5 |
17 | 29.3 |
1432 | 17.2 |
0 | 0.0 |
Proline metabolism |
M00973 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Anammox, nitrite + ammonia => nitrogen |
M00974 |
409 | 40.1 |
0 | 0.0 |
409 | 64.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Betaine metabolism, animals, betaine => glycine |
M00975 |
0 | 0.0 |
600 | 6.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
600 | 7.2 |
0 | 0.0 |
Betaine degradation, bacteria, betaine => pyruvate |
M00976 |
390 | 38.2 |
0 | 0.0 |
390 | 61.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C19-Steroid hormone biosynthesis, pregnenolone => testosterone => dihydrotestosterone |
M00977 |
156 | 15.3 |
0 | 0.0 |
156 | 24.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C19-Steroid hormone biosynthesis (androgen backdoor pathway), pregnenolone => androsterone => dihydrotestosterone |